Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 2 (2007), Issue 7 (July)

1. Genotyping of hepatitis C virus isolates by a new line probe assay using sequence information from both the 5'untranslated and the core regions.
   J Virol Methods, 143(2): 153-60. [Abstract] [Full-text]
2. Hepatic (64)Cu excretion in Dobermanns with subclinical hepatitis.
   Res Vet Sci, 83(2): 204-9. [Abstract] [Full-text]
3. Infectious canine hepatitis: an "old" disease reemerging in Italy.
   Res Vet Sci, 83(2): 269-73. [Abstract] [Full-text]
4. Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1.
   Nat Clin Pract Gastroenterol Hepatol, 4(7): 403-8. [Abstract] [Full-text]
5. Analysis of the full-length genome of hepatitis E virus isolates obtained from farm pigs in Mongolia.
   J Med Virol, 79(8): 1128-37. [Abstract] [Full-text]
6. Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.
   J Med Virol, 79(8): 1095-102. [Abstract] [Full-text]
7. Determining the source of nosocomial transmission in hemodialysis units in Tunisia by sequencing NS5B and E2 sequences of HCV.
   J Med Virol, 79(8): 1089-94. [Abstract] [Full-text]
8. Identification of genotype 4 hepatitis E virus strains from a patient with acute hepatitis E and farm pigs in Bali, Indonesia.
   J Med Virol, 79(8): 1138-46. [Abstract] [Full-text]
9. Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.
   J Med Virol, 79(8): 1113-9. [Abstract] [Full-text]
10. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    J Med Virol, 79(8): 1064-74. [Abstract] [Full-text]
11. Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
    J Med Virol, 79(8): 1055-63. [Abstract] [Full-text]
12. Hepatitis C virus infection and genotypes in Antananarivo, Madagascar.
    J Med Virol, 79(8): 1082-8. [Abstract] [Full-text]
13. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.
    J Med Virol, 79(8): 1075-81. [Abstract] [Full-text]
14. Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection.
    Tissue Antigens, 70(2): 160-3. [Abstract] [Full-text]
15. Chronic hepatitis C virus infection: a review for pharmacists.
    J Am Pharm Assoc (2003), 47(4): 508-20; quiz 508-20. [Abstract] [Full-text]
16. Molecular and epidemiological study on nosocomial transmission of HCV in hemodialysis patients in Brazil.
    J Med Virol, 79(9): 1325-33. [Abstract] [Full-text]
17. Virological features of hepatitis B virus-associated nephropathy in Japan.
    J Med Virol, 79(9): 1305-11. [Abstract] [Full-text]
18. Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients.
    J Med Virol, 79(9): 1293-304. [Abstract] [Full-text]
19. Proteasomal degradation of core protein variants from chronic hepatitis B patients.
    J Med Virol, 79(9): 1312-21. [Abstract] [Full-text]
20. Prevalence and common genotypes of HCV infection in Sudanese patients with hepatosplenic schistosomiasis.
    J Med Virol, 79(9): 1322-4. [Abstract] [Full-text]
21. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    J Med Virol, 79(9): 1286-92. [Abstract] [Full-text]
22. Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients.
    J Acquir Immune Defic Syndr, 45(4): 439-44. [Abstract] [Full-text]
23. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.
    N Engl J Med, 357(2): 124-34. [Abstract] [Full-text]
24. Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients.
    Gut, 56(8): 1111-6. [Abstract] [Full-text]
25. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.
    Gut, 56(8): 1098-104. [Abstract] [Full-text]
26. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt.
    Gut, 56(8): 1105-10. [Abstract] [Full-text]
27. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.
    Eur J Haematol, 79(2): 132-7. [Abstract] [Full-text]
28. Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions.
    Clin Infect Dis, 45(4): e32-8. [Abstract] [Full-text]
29. Genetic analysis of HAV strains in Tunisia reveals two new antigenic variants.
    Virus Genes, 35(2): 155-9. [Abstract] [Full-text]
30. Hepatotoxic and immunotoxic effects produced by 1,3-dibromopropane and its conjugation with glutathione in female BALB/c mice.
    J Toxicol Environ Health A, 70(15): 1381-90. [Abstract] [Full-text]
31. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
    Transfusion, 47(8): 1534-9. [Abstract] [Full-text]
32. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities.
    CMAJ, 177(3): 257-61. [Abstract] [Full-text]
33. Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons.
    CMAJ, 177(3): 252-6. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.